Phase II study of tailored-dose docetaxel + trastuzumab in Her-2 positive metastatic breast cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docetaxel; Trastuzumab
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 05 Oct 2012 Biomarkers information updated
- 06 Feb 2012 Actual patient number is 22 according to ClinicalTrials.gov.
- 06 Feb 2012 Actual end date (Mar 2005) added as reported by ClinicalTrials.gov.